perflutren has been researched along with transforming growth factor beta in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heriot, W; Luckie, A | 1 |
| Glaser, BM; Hanham, A; Murphy, RP; Sjaarda, RN; Thompson, JT | 1 |
| Glaser, BM; Gordon, LW; Ie, D; Sjaarda, RN; Thompson, JT | 1 |
| Glaser, BM; Murphy, RP; Sjaarda, RN; Thompson, JT | 1 |
| de la Cruz, Z; Glaser, BM; Green, WR; Rosa, RH | 1 |
| Glaser, BM; Murphy, RP; Pappas, SS; Rubin, JS; Sjaarda, RN; Thompson, JT | 1 |
| Lansing, MB; Sjaarda, RN; Thompson, JT | 1 |
1 review(s) available for perflutren and transforming growth factor beta
| Article | Year |
|---|---|
Macular holes. Pathogenesis, natural history and surgical outcomes.
Topics: Aged; Diagnosis, Differential; Female; Fluorescein Angiography; Fluorocarbons; Fundus Oculi; Growth Substances; Humans; Male; Retina; Retinal Perforations; Transforming Growth Factor beta; Treatment Outcome; Visual Acuity; Vitrectomy | 1995 |
1 trial(s) available for perflutren and transforming growth factor beta
| Article | Year |
|---|---|
Increased intraocular pressure after macular hole surgery.
Topics: Chemotherapy, Adjuvant; Double-Blind Method; Fluorocarbons; Humans; Incidence; Intraocular Pressure; Ocular Hypertension; Postoperative Complications; Prospective Studies; Recombinant Proteins; Retinal Perforations; Risk Factors; Time Factors; Transforming Growth Factor beta; Vitrectomy | 1996 |
5 other study(ies) available for perflutren and transforming growth factor beta
| Article | Year |
|---|---|
Effects of intraocular bubble duration in the treatment of macular holes by vitrectomy and transforming growth factor-beta 2.
Topics: Aged; Air; Combined Modality Therapy; Female; Fluorocarbons; Humans; Male; Middle Aged; Prospective Studies; Retinal Perforations; Time Factors; Transforming Growth Factor beta; Treatment Outcome; Visual Acuity; Vitrectomy | 1994 |
Retreatment of full-thickness macular holes persisting after prior vitrectomy. A pilot study.
Topics: Adult; Aged; Fluorocarbons; Follow-Up Studies; Humans; Middle Aged; Pilot Projects; Reoperation; Retinal Perforations; Transforming Growth Factor beta; Visual Acuity; Vitrectomy | 1993 |
Clinicopathologic correlation of an untreated macular hole and a macular hole treated by vitrectomy, transforming growth factor-beta 2, and gas tamponade.
Topics: Aged; Cell Division; Eye Enucleation; Fluorescein Angiography; Fluorocarbons; Fovea Centralis; Fundus Oculi; Humans; Male; Neuroglia; Ophthalmic Solutions; Retina; Retinal Perforations; Transforming Growth Factor beta; Visual Acuity; Vitrectomy | 1996 |
Vitrectomy, fluid-gas exchange and transforming growth factor--beta-2 for the treatment of traumatic macular holes.
Topics: Adolescent; Adult; Air; Child; Eye Injuries; Female; Fluorescein Angiography; Fluorocarbons; Follow-Up Studies; Humans; Male; Ophthalmic Solutions; Recombinant Proteins; Reoperation; Retina; Retinal Perforations; Transforming Growth Factor beta; Treatment Outcome; Visual Acuity; Vitrectomy; Wounds, Nonpenetrating | 1995 |
The results of vitreous surgery for chronic macular holes.
Topics: Adult; Aged; Blood Platelets; Chronic Disease; Female; Fluorescein Angiography; Fluorocarbons; Follow-Up Studies; Fundus Oculi; Humans; Male; Middle Aged; Recombinant Proteins; Retinal Perforations; Retrospective Studies; Transforming Growth Factor beta; Treatment Outcome; Visual Acuity; Vitrectomy | 1997 |